Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Appointed director
Quarterly results
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results -Conference Call and Webcast Today, August 7, 2023 at 4:30 p.m. ET"
05/02/2023 8-K Quarterly results
03/20/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/06/2023 8-K Quarterly results
01/30/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "3.1 1 SECOND AMENDED AND RESTATED BYLAWS OF ARROWHEAD PHARMACEUTICALS, INC. ARTICLE I STOCKHOLDERS"
12/08/2022 8-K Quarterly results
11/28/2022 8-K Quarterly results
11/10/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
08/04/2022 8-K Quarterly results
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results –Conference Call and Webcast Today, August 4, 2022 at 4:30 p.m. ET"
07/19/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/25/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Arrowhead Pharmaceuticals and Vivo Capital Launch Joint Venture Aimed at Greater China Market"
03/18/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
02/02/2022 8-K Quarterly results
12/20/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Arrowhead Initiates Project to Build New Manufacturing and Lab Facilities"
12/16/2021 8-K Quarterly results
11/22/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2021 Year End Results - Conference Call and Webcast Today, November 22, 2021 at 4:30 p.m. ET"
08/27/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/22/2021 8-K Quarterly results
06/16/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
03/24/2021 8-K Quarterly results
02/04/2021 8-K Quarterly results
11/23/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2020 Year End Results - Conference Call and Webcast Today, November 23 at 4:30 p.m. EST"
10/09/2020 8-K Quarterly results
09/08/2020 8-K Quarterly results
08/05/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
05/01/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/19/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy